Early response to upadacitinib in moderate-to-severe atopic dermatitis: Results from a phase 2b randomized, placebo-controlled trial

被引：0
|
作者：
Reich, K. [1 ,2 ]
Guttman-Yassky, E. [3 ]
Beck, L. A. [4 ]
Hu, X. [5 ]
Pangan, A. L. [5 ]
Teixeira, H. D. [5 ]
机构：
[1] SCIderm Res Inst, Hamburg, Germany
[2] Dermatologikum Hamburg, Hamburg, Germany
[3] Icahn Sch Med Mt Sinai, Med Ctr, New York, NY 10029 USA
[4] Univ Rochester, Med Ctr, Rochester, NY 14627 USA
[5] AbbVie Inc, N Chicago, IL USA
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0135
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] UPADACITINIB EFFECT ON PRURITUS IN MODERATE-TO-SEVERE ATOPIC DERMATITIS; FROM A PHASE 2B RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Beck, L.
    Hong, C.
    Hu, X.
    Chen, S.
    Calimlim, B.
    Teixeira, H.
    Guttman-Yassky, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S21 - S21
  • [2] Upadacitinib improved patient-reported pruritus in moderate-to-severe atopic dermatitis: results from a phase 2B randomized, placebo-controlled trial
    Hong, C. -H.
    Wu, T.
    Calimlim, B.
    Teixeira, H.
    de Bruin-Weller, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 10 - 10
  • [3] Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial
    Guttman-Yassky, Emma
    Silverberg, Jonathan I.
    Thaci, Diamant
    Papp, Kim A.
    Staender, Sonja
    Beck, Lisa A.
    Kim, Brian S.
    Hu, Xiaofei
    Liu, Jianzhong
    Calimlim, Brian M.
    Vigna, Namita
    Crowley, Jameson T.
    Teixeira, Henrique D.
    Thyssen, Jacob P.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : 2558 - 2568
  • [4] Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis from a phase 2b, randomized, controlled trial
    Guttman-Yassky, Emma
    Beck, Lisa A.
    Anderson, Jaclyn K.
    Hu, Xiaofei
    Gu, Yihua
    Teixeira, Henrique D.
    Silverberg, Jonathan I.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB294 - AB294
  • [5] The patient-reported burden of atopic dermatitis and its association with itch: Observations from the upadacitinib phase 2b randomized, placebo-controlled trial in moderate to severe atopic dermatitis
    Silverberg, Jonathan I.
    Calimlim, Brian
    Teixeira, Henrique D.
    Wu, Meijing
    Simpson, Eric L.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB77 - AB77
  • [6] Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
    Guttman-Yassky, Emma
    Thaci, Diamant
    Pangan, Aileen L.
    Hong, H. Chih-ho
    Papp, Kim A.
    Reich, Kristian
    Beck, Lisa A.
    Mohamed, Mohamed-Eslam F.
    Othman, Ahmed A.
    Anderson, Jaclyn K.
    Gu, Yihua
    Teixeira, Henrique D.
    Silverberg, Jonathan I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (03) : 877 - 884
  • [7] Upadacitinib improved patient-reported sleep in moderate-to-severe atopic dermatitis: results from a phase zb randomized, placebo controlled trial
    Reich, K.
    Liu, M.
    Calimlim, B.
    Teixeira, H. D.
    Silverberg, J. I.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 60 - 61
  • [8] Achieving an itch-free state with Upadacitinib: a post-hoc analysis of data from the Phase 2b randomized, doubleblind, placebo-controlled trial in moderate-to-severe atopic dermatitis
    Silverberg, J.
    Reich, K.
    Calimlim, B., III
    Gu, Y.
    Hu, X.
    Teixera, H.
    Guttman-Yassky, E.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 37 - 37
  • [9] Time to Upadacitinib treatment response over 16 weeks for patients with atopic dermatitis from Phase 2b randomized, placebo-controlled trial
    Reich, Kristian
    Guttman-Yassky, Emma
    Hu, Xiaofei
    Calimlim, Brian
    Teixeira, Henrique
    de Bruin-Weller, Marjolein
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 18 - 19
  • [10] EFFICACY AND SAFETY OF CM310 IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2B TRIAL IN CHINA
    Zhang, Jianzhong
    Yang, Bin
    Li, Jingyi
    Ding, Yangfeng
    Wu, Liming
    Zhang, Litao
    Wang, Jinyan
    Zhu, Xiaohong
    Zhang, Furen
    Tao, Xiaohua
    Li, Yumei
    Zhang, Chunlei
    Li, Linfeng
    Lu, Jianyun
    Diao, Qingchun
    Lu, Qianjin
    Man, Xiaoyong
    Li, Fuqiu
    Xia, Xiujuan
    Cheng, Hao
    Zhao, Yan
    Chen, Bo
    Yan, Jinchun
    Zhao, Guoqing
    Jia, Yingmin
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 20 - 20
12345